XML 42 R33.htm IDEA: XBRL DOCUMENT
v3.23.3

INCOME (LOSS) PER SHARE (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2023
Earnings Per Share [Abstract] |
Schedule of Computation of Basic and Diluted Net Income (Loss) Per Share of Common Stock | The following table sets forth the computation of basic and diluted net income (loss) per share of common stock for the three and nine months ended September 30, 2023 and 2022 (in thousands, except share amounts and per share amounts):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
Basic and diluted net income (loss) per share: |  |  |  |  |  |  |
Numerator |  |  |  |  |  |  |
Net income (loss) | $ | (40,806) |  |  | $ | (55,543) |  |  | $ | (81,423) |  |  | $ | (180,145) |
Less: Net income (loss) attributable to noncontrolling interests | 552 |  |  | 680 |  |  | 1,689 |  |  | 2,157 |
Net income (loss) attributable to common stockholders | (41,358) |  |  | (56,223) |  |  | (83,112) |  |  | (182,302) |
Denominator |  |  |  |  |  |  |
Weighted-average common shares outstanding | 31,500,489 |  |  | 30,307,734 |  |  | 31,039,668 |  |  | 30,070,598 |
Basic and diluted net income (loss) per share: | $ | (1.31) |  |  | $ | (1.86) |  |  | $ | (2.68) |  |  | $ | (6.06) |
Schedule of Weighted-Average Potentially Dilutive Instruments | The following weighted-average potentially dilutive instruments are not included in the diluted net income (loss) per share calculations above because they would have had an antidilutive effect on the net income (loss) per share:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
Restricted stock units | 1,108,379 |  |  | 2,223,826 |  |  | 1,695,383 |  |  | 2,448,348 |
Stock options | 3,309,783 |  |  | — |  |  | 2,282,890 |  |  | — |
Other stock-based compensation awards(1) | 7,923 |  |  | 94,690 |  |  | 35,078 |  |  | 102,406 |
Convertible Senior notes due 2026 (2) | 3,376,400 |  |  | 3,376,400 |  |  | 3,376,400 |  |  | 3,376,400 |
Capped call transactions | 3,376,400 |  |  | 3,376,400 |  |  | 3,376,400 |  |  | 3,376,400 |
Total | 11,178,885 |  |  | 9,071,316 |  |  | 10,766,151 |  |  | 9,303,554 |
(1)We had outstanding performance share units as of September 30, 2023 and 2022 that were eligible to vest into shares of common stock subject to the achievement of specified performance or market conditions. Contingently-issuable shares are excluded from the computation of diluted income (loss) per share if, based on current period results, the shares would not be issuable if the end of the reporting period were the end of the contingency period. As of September 30, 2023, there were up to 724,487 shares of common stock issuable upon vesting of outstanding Performance Share Units that were excluded from the table above as the performance conditions were not satisfied as of the end of the period. (2)We apply the if-converted method in computing the effect of our convertible senior notes on diluted net income (loss) per share, whereby the numerator of our diluted net income (loss) per share computations is adjusted for interest expense, net of tax, and the denominator is adjusted for the number of shares into which the convertible senior notes could be converted. The effect is only included in the calculation of income (loss) per share for those instruments for which it would reduce income (loss) per share. See Note 5, Financing Arrangements, for additional information.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration